Company: WHWK
Filing Date: 2025-01-31
Form Type: DEFM14A
Source: 0001193125-25-018470
Chunk: 195

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-31
Form: DEFM14A
Chunk 195
---
 2017 Stock Plan and Incentive Plan or the Aerpio Pharmaceuticals, Inc. 2011 Equity Incentive Plans (the “Prior Plans”) that expire or otherwise terminate without having been exercised in full and shares issued pursuant to awards granted under the Prior Plans that are forfeited to or repurchased by the Company, and (iii) any Shares subject to stock options or similar awards granted under the Aadi Bioscience, Inc. 2014 Equity Incentive Plan that are assumed by the Company in connection with the reverse merger between Aadi Sub and Aadi (f/k/a Aerpio Pharmaceuticals, Inc.) in August 2021 (the “Reverse Merger”), with the maximum number of shares to be added to the 2021 Plan pursuant to clauses (ii) and (iii) equal to 764,154 shares (the “Rollover Shares”). Upon stockholder approval of the Amended and Restated Plan, the total number of shares authorized for issuance under the Amended and Restated Plan under the preceding clause (i) will be 8,370,784, of which 8,300,284 shares will be available for future awards, plus (x) the remaining Rollover Shares (of which 208,488 remain subject to outstanding awards under the Prior Plans or the Aadi Bioscience, Inc. 2014 Equity Incentive Plan), and (y) any shares added to the Amended and Restated Plan under the “evergreen” provision described below. The shares may be authorized, but unissued or reacquired common stock. Under the “evergreen” provision, the number of shares of our common stock authorized for issuance under our 2021 Plan has increased annually on the first day of each fiscal year of ours beginning with our 2022 fiscal year, equal to the least of:

| • |     | 2,070,784 shares of our common stock; |

| • |     | 4% of the outstanding shares of all classes of our common stock as of the last day of the immediately preceding 
 fiscal year; or                                                                                                 |

- 136 -

| • |     | such other amount as the Administrator (as defined below) may determine no later than the last day of the 
 immediately preceding fiscal year.                                                                        |

The “evergreen” provision of the 2021 Plan will terminate following the increase on the first day of our 2031 fiscal year. On January 20, 2025, upon recommendation of